Slover Peter T 4
4 · SOPHIRIS BIO INC. · Filed Dec 23, 2019
Insider Transaction Report
Form 4
Slover Peter T
Chief Financial Officer
Transactions
- Award
Common Stock (Right to Buy)
2019-12-19$0.36/sh+103,000$37,080→ 103,000 totalExercise: $0.36From: 2020-12-19Exp: 2029-12-18→ Common Stock (103,000 underlying)
Footnotes (1)
- [F1]33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on December 19, 2022.